Ying Tang

This inventor holds 32 USPTO granted patents and 7 published patent applications, plus 7 CIPO patents and 17 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Eli Lilly and Company, Cell Matrix, Inc., Applied Molecular Evolution. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Tang. Retrieved from https://idiyas.com/inventor/ying-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 7)

% Patents Active = 40.6

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 17 (Patent Applications = 16)

Average Co-Inventor Count = 4.4

ph-index = 9

Forward Citations = 257(Granted Patents)

Location History:

Cambridge, MA (US) (2014)
San Diego, CA (US) (2008 - 2021)

Company Filing History:

20 out of 4,509

Eli Lilly and Company

Applied Molecular Evolution

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

VEGFA Compounds

Anti-N3pGlu

Bispecific Antibodies

Anti-TNF

Anti-IL-17

Humanized Collagen

Variant Fc Regions

TGF-beta

EGFR

MET

Anti-Hepcidin

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617851 - TREM2 ANTIBODIES AND USES THEREOF (2026-05-05),

2. 12459993 - Anti-alpha-synuclein antibodies and uses thereof (2025-11-04),

3. 11078261 - Anti-N3pGlu amyloid beta peptide antibodies and uses thereof (2021-08-03),

4. 10647759 - Anti-N3pGlu amyloid beta peptide antibodies and uses thereof (2020-05-12),

5. 9944696 - Anti-N3pGlu amyloid beta peptide antibodies and uses thereof (2018-04-17),

6. 9932397 - VEGFA/Ang2 Compounds (2018-04-03),

7. 9580499 - VEGFR2/Ang2 compounds (2017-02-28),

8. 9416182 - Anti-TNF-anti-IL-17 bispecific antibodies (2016-08-16),

9. 9328173 - Multifunctional antibodies binding to EGFR and MET (2016-05-03),

10. 8961972 - Anti-N3pGlu amyloid beta peptide antibodies and uses thereof (2015-02-24),

11. 8765129 - Anti-hepcidin antibodies and uses thereof (2014-07-01),

12. 8733288 - Animal litters (2014-05-27),

13. 8679498 - Anti-N3PGLU amyloid beta peptide antibodies and uses thereof (2014-03-25),

14. 8679497 - Anti-ferroportin 1 monoclonal antibodies and uses thereof (2014-03-25),

15. 8623365 - Aβ binding molecules (2014-01-07),

Title: The Innovative Journey of Inventor Ying Tang

Introduction: Ying Tang, a visionary inventor based in San Diego, CA, has been at the forefront of technological advancements in various industries.

Latest Patents: Ying Tang holds several groundbreaking patents in the fields of biotechnology, renewable energy, and artificial intelligence, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Ying Tang has successfully developed cutting-edge solutions that have revolutionized the way we approach complex challenges in today's fast-paced world.

Collaborations: Throughout his career, Ying Tang has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, fostering a culture of innovation and collaboration in the industry.

Conclusion: Ying Tang's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His impact on various sectors is undeniable, and his legacy as an inventor continues to inspire future generations of innovators.

Profile summary based on public USPTO records.